Jacqueline Plowman - Concepedia

Author

Jacqueline Plowman

National Cancer Institute

Also Known As

J Plowman, J. PLOWMAN, J. Plowman, Jacqueline P. Plowman, Jacqueline Plowman, Plowman, Jacqueline

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health National Cancer Institute Southern Research Institute National Cancer Institute

About

Jacqueline Plowman is an author at National Cancer Institute specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	30	1.8K
2	Natural Sciences	7	7	262
3	Biochemistry	7	7	220
4	Engineering	2	2	42
5	Biomolecular Engineering	2	2	42

Jacqueline Plowman

Publications

Citations

H-Index

Page 1

	Year	Citations
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes, JNCI Journal of the National Cancer Institute	1989	960
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione Robert F. Ozols, Karen G. Louie, Jacqueline Plowman, Biochemical Pharmacology Buthionine Sulfoximine DepletionOncogenic AgentMedicineHuman Ovarian CancerAnti-cancer Agent	1987	205
2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases R. K. ROBINS, Prem C. Srivastava, V. L. Narayanan, Journal of Medicinal Chemistry Chemoprevention StrategyAltmetric Attention ScorePathologyPharmacotherapyPre-clinical Pharmacology	1982	147
Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives Ernest Hamel, Chii M. Lin, Jacqueline Plowman, Biochemical Pharmacology Medicinal ChemistryDerivative (Chemistry)MedicineHeterocycle ChemistryPharmacology	1996	139
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Jacqueline Plowman, V. L. Narayanan, Donald J. Dykes, PubMed PathologyPharmacotherapyTumor ImplantationTumor BiologyOncology	1986	138
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Jacqueline Plowman, William R. Waud, Antonis D. Koutsoukos, PubMed Tumor Growth DelayU251 ModelPharmacotherapyHigh-grade GliomasGlioma	1994	132
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice Thomas H. Corbett, Marie-Christine Bissery, Antoinette Wozniak, Investigational New Drugs Flavone Acetic AcidSolid TumorsMedicineOncogenic AgentPharmacology	1986	122
Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors. Daniel L. Dexter, David P. Hesson, Robert Ardecky, PubMed Molecular PharmacologyMedicinal ChemistryNovel 4-Quinolinecarboxylic AcidExperimental TumorsL1210 Leukemia	1985	104
Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. Wilbur R. Leopold, James M. Nelson, Jacqueline Plowman, PubMed Combinatorial ChemistryMedicinal ChemistryAnthracenediones MitoxantroneMedicineAnthracene System	1985	86
Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties Víctor E. Márquez, Mu Ill Lim, Susan P. Treanor, Journal of Medicinal Chemistry	1988	81

Page 1